1. Introduction {#sec1-nutrients-11-00048}
===============

The number of people with diabetes is increasing rapidly, worldwide. The International Diabetes Federation reported that in 2015, 415 million adults had diabetes and that by 2040, this number is expected to rise to 642 million \[[@B1-nutrients-11-00048]\]. In 2015, the global economic burden associated with diabetes reached US\$1.31 trillion, becoming a substantial global economic burden \[[@B2-nutrients-11-00048]\]. Therefore, low-cost and easily accessible strategies for preventing diabetes are required. Globally, coffee and tea are widely consumed beverages and their consumption is integrated into people's daily lives. A large body of epidemiological evidence, from prospective cohort studies, suggests a strong association between coffee/tea consumption and a decreased risk of diabetes \[[@B3-nutrients-11-00048],[@B4-nutrients-11-00048],[@B5-nutrients-11-00048],[@B6-nutrients-11-00048]\]. If the associations are causal, there would be substantial public health implications. However, whether or not these beverages reduce glucose metabolism remains uncertain. Previous meta-analyses of clinical trial data have investigated the effects of coffee or tea consumption on glucose metabolism \[[@B7-nutrients-11-00048],[@B8-nutrients-11-00048],[@B9-nutrients-11-00048]\]. Unfortunately, these meta-analyses have not evaluated tea and coffee comprehensively; have included duplicate studies \[[@B7-nutrients-11-00048]\]; have evaluated only acute effects \[[@B10-nutrients-11-00048]\]; and did not evaluate the quality of evidence across studies \[[@B7-nutrients-11-00048],[@B8-nutrients-11-00048],[@B9-nutrients-11-00048]\], using approaches such as the Grading of Recommendations Assessment Development and Evaluation (GRADE) system \[[@B11-nutrients-11-00048]\]. Together, these weaknesses limit the interpretation of the results and provide insufficient information to make relevant judgments.

Network meta-analysis (NMA) is a method that enables the comparison of multiple interventions using direct and indirect comparison evidence even when direct comparisons of data are insufficient \[[@B12-nutrients-11-00048]\]. Hence, we performed a systematic review that involved an NMA, using the GRADE system to comprehensively evaluate the effects of coffee and tea consumption on glucose metabolism.

2. Materials and Methods {#sec2-nutrients-11-00048}
========================

2.1. Literature Search {#sec2dot1-nutrients-11-00048}
----------------------

This study was conducted according to a predetermined protocol (PROSPERO \# CRD42015029597) developed using the Preferred Reporting Items for Systematic Reviews and Meta-Analysis for Protocols \[[@B13-nutrients-11-00048],[@B14-nutrients-11-00048]\]. We systematically searched PubMed, Embase, and the Cochrane library for eligible randomized, controlled clinical trials published before February 19, 2017 without any language restrictions. The literature search involved querying the terms "coffee," "tea," "glucose," "HbA1c," "insulin," "insulin resistance," and "randomized controlled trial (RCT)." In addition, we manually searched the references included in each original article retrieved. The details of the literature search strategy are described in the [Supplementary Table S1](#app1-nutrients-11-00048){ref-type="app"}.

2.2. Study Selection {#sec2dot2-nutrients-11-00048}
--------------------

We included studies examining the effects of caffeinated coffee, decaffeinated coffee, black tea, oolong tea, and green tea (caffeinated or decaffeinated), given as a drink or crude extract, with follow-up durations of at least 2 weeks. We excluded studies examining multi-nutrient supplements, in addition to coffee or tea as interventions. Studies were selected for this analysis only if they also described an RCT in human adults involving either a parallel or crossover design and had at minimum, fasting blood glucose (FBG) or hemoglobin A1c (HbA1c) results available for each group. In cases involving multiple publications of the same study, the most informative article was included.

2.3. Data Extraction {#sec2dot3-nutrients-11-00048}
--------------------

Two investigators extracted data independently and resolved any discrepancies through discussion. The extracted information included study characteristics (authors, design, publication year, sample size, duration of intervention, and follow-up), participant characteristics (age, sex, ethnicity, body mass index, HbA1c, FBG concentration), 2-h post-load glucose concentration from an oral glucose tolerance test (75-g OGTT 2h-PG), fasting blood insulin (fasting IRI) concentration, homeostasis model assessment for insulin resistance (HOMA-IR) and HOMA-ß, and intervention (type of tea or coffee).

2.4. Risk of Bias Assessment {#sec2dot4-nutrients-11-00048}
----------------------------

The risk of bias was assessed using Cochrane's risk of bias tool \[[@B15-nutrients-11-00048]\]. In addition, quality of evidence was assessed using the GRADE system \[[@B11-nutrients-11-00048]\].

2.5. Strategy for Data Synthesis {#sec2dot5-nutrients-11-00048}
--------------------------------

We examined the effects of the studied interventions after combining green tea and green tea extract into a single group referred to as green tea. Decaffeinated green tea and decaffeinated green tea extract interventions were also combined into a single decaffeinated green tea group. A standard, pairwise meta-analysis was conducted for each pairwise direct comparison of interventions (caffeinated coffee, decaffeinated coffee, black tea, oolong tea, caffeinated green tea, and decaffeinated green tea). The outcome data (post-intervention values) were extracted for subsequent analyses. When studies reported data for different durations of intervention, the duration for the pre-defined primary endpoint in each study, was used in the analyses. If the standard deviations of the endpoints were missing, pooled standard deviations were calculated from the other included studies \[[@B16-nutrients-11-00048]\]. We used a random-effects model to incorporate the assumption that different studies estimated different yet related intervention effects. Publication biases or small study effects were examined using conventional funnel plots.

In addition, we conducted network meta-analyses within the frequentist framework using multivariate random-effects meta-analysis models, which consider the heterogeneity of effects across studies. The results for the comparative effects are presented as mean difference estimates and 95% confidence intervals (CIs). We plotted a comparison-adjusted funnel plot to detect the presence of publication bias in the network meta-analysis. We also evaluated the ranking of the intervention effect, i.e., the most efficacious beverage, second best, third best, etc. Inconsistency between the direct and indirect evidence on the network was evaluated using global and local inconsistency tests \[[@B17-nutrients-11-00048]\].

Stata 14 software (Stata, College Station, TX, USA) was used for the analyses. The "metan" package \[[@B18-nutrients-11-00048]\] was used to conduct the pairwise random-effects meta-analyses and the "metareg" package \[[@B19-nutrients-11-00048]\] was used for the meta-regression analyses; the "network" package \[[@B20-nutrients-11-00048]\] was used for the NMAs. The *p*-values \< 0.05 were considered statistically significant.

2.6. Subgroup or Subset Analysis {#sec2dot6-nutrients-11-00048}
--------------------------------

In the pairwise direct comparison meta-analyses, the heterogeneity of the intervention effects across studies were investigated using the heterogeneity test and the I^2^ statistic.

The sources of possible clinical heterogeneity were listed a priori, such as age, sex, ethnicity, body mass index, baseline fasting blood glucose level, and the baseline HbA1c level. Among these, data on age, sex, ethnicity, body mass index, baseline fasting blood glucose level were available. These were examined as effect modifiers in the meta-regression or subgroup analyses. Sensitivity analyses were also conducted for assessing possible biases.

3. Results {#sec3-nutrients-11-00048}
==========

3.1. Study Selection and Characteristics {#sec3dot1-nutrients-11-00048}
----------------------------------------

Of the 892 citations identified, 27 studies involving 1898 subjects were included in our meta-analysis ([Figure 1](#nutrients-11-00048-f001){ref-type="fig"}) \[[@B21-nutrients-11-00048],[@B22-nutrients-11-00048],[@B23-nutrients-11-00048],[@B24-nutrients-11-00048],[@B25-nutrients-11-00048],[@B26-nutrients-11-00048],[@B27-nutrients-11-00048],[@B28-nutrients-11-00048],[@B29-nutrients-11-00048],[@B30-nutrients-11-00048],[@B31-nutrients-11-00048],[@B32-nutrients-11-00048],[@B33-nutrients-11-00048],[@B34-nutrients-11-00048],[@B35-nutrients-11-00048],[@B36-nutrients-11-00048],[@B37-nutrients-11-00048],[@B38-nutrients-11-00048],[@B39-nutrients-11-00048],[@B40-nutrients-11-00048],[@B41-nutrients-11-00048],[@B42-nutrients-11-00048],[@B43-nutrients-11-00048],[@B44-nutrients-11-00048],[@B45-nutrients-11-00048],[@B46-nutrients-11-00048],[@B47-nutrients-11-00048]\]. The characteristics of the included studies are shown in [Table 1](#nutrients-11-00048-t001){ref-type="table"}. Of these studies, effects were reported on FBG concentrations (26 studies), 75-g OGTT 2h-PG concentrations (4 studies), HbA1c (10 studies), fasting IRI concentrations (13 studies), and HOMA-IR (8 studies); no studies reported results on HOMA-ß. [Figure 2](#nutrients-11-00048-f002){ref-type="fig"} shows the network plots of eligible comparisons for FBG, 75-g OGTT 2h-PG, HbA1c, fasting IRI, and HOMA-IR. Six classes of interventions (coffee, decaffeinated coffee, green tea, decaffeinated green tea, black tea, oolong tea) had adequate numbers of studies for NMA. The effects of coffee and decaffeinated coffee were indirectly and directly compared. The differences between direct and indirect evidence in closed loops in the network showed no indication of inconsistency.

3.2. Risk of Bias for Included Studies {#sec3dot2-nutrients-11-00048}
--------------------------------------

The included studies generally had unclear or high risks of bias for random sequence generation, allocation concealment, blinding of participants and personnel, blinding of outcome assessments, and selective outcome reporting. The Cochrane risk of bias analysis indicated among the studies with a high risk of bias, blinding of the participants and personnel was highest (51.9%); selective reporting contributed the most to the unclear-domain bias (63.0%). Furthermore, 59.3% of the studies were judged to have an unclear or high risk of bias for either domain or selection bias, which may have seriously distorted the validity of each study. Details regarding the risk of biases are shown in [Figure 3](#nutrients-11-00048-f003){ref-type="fig"}.

3.3. Primary Endpoint: FBG {#sec3dot3-nutrients-11-00048}
--------------------------

Twenty-six studies reported effects on FBG concentrations. Of these, 2 \[[@B22-nutrients-11-00048],[@B23-nutrients-11-00048]\] reported the effects of both coffee and decaffeinated coffee on FBG concentrations. Thus, the effects on FBG concentrations were reported for coffee (4 studies \[[@B21-nutrients-11-00048],[@B22-nutrients-11-00048],[@B23-nutrients-11-00048],[@B24-nutrients-11-00048]\]), decaffeinated coffee (2 studies \[[@B22-nutrients-11-00048],[@B23-nutrients-11-00048]\]), black tea (3 studies \[[@B25-nutrients-11-00048],[@B26-nutrients-11-00048],[@B27-nutrients-11-00048]\]), green tea (11 studies \[[@B28-nutrients-11-00048],[@B29-nutrients-11-00048],[@B30-nutrients-11-00048],[@B31-nutrients-11-00048],[@B32-nutrients-11-00048],[@B33-nutrients-11-00048],[@B34-nutrients-11-00048],[@B35-nutrients-11-00048],[@B36-nutrients-11-00048],[@B37-nutrients-11-00048],[@B39-nutrients-11-00048]\]), decaffeinated green tea (6 studies \[[@B40-nutrients-11-00048],[@B41-nutrients-11-00048],[@B42-nutrients-11-00048],[@B43-nutrients-11-00048],[@B44-nutrients-11-00048],[@B45-nutrients-11-00048]\]), oolong tea (2 studies \[[@B46-nutrients-11-00048],[@B47-nutrients-11-00048]\]).

A direct pairwise meta-analysis (−2.10 mg/dL; 95% CI, −3.93 to −0.27 mg/dL; *p* = 0.02) and NMA for studies with a moderate quality of evidence (−2.10 mg/dL; 95% CI, −3.96 to −0.24 mg/dL; *p* = 0.03) suggested that green tea consumption slightly but significantly reduced FBG concentrations compared with placebo/water ([Table 2](#nutrients-11-00048-t002){ref-type="table"}, [Figure 4](#nutrients-11-00048-f004){ref-type="fig"}).

The meta-regression analysis showed a tendency for the FBG reductive effect of green tea to be stronger in studies with a mean age \< 55-years-old than in studies with an older mean age (β = 0.17; standard error (SE), 0.10; 95% CI, −0.04 to 0.41; *p* = 0.10; [Supplemental Figure S1a](#app1-nutrients-11-00048){ref-type="app"}). In the NMA, stratified by mean participant age, the effect of green tea on FBG concentrations was significant only in younger individuals (age \< 55: −2.51 mg/dL; 95% CI, −4.67 to −0.35; *p* = 0.02; age ≥ 55: −0.72 mg/dL; 95% CI, −4.61 to 3.17 mg/dL; *p* = 0.72). In the direct pairwise meta-analysis, stratified by Asian-based studies and non-Asian-based studies, the effect of green tea on FBG concentrations was significant only in Asian-based studies (Asian: −3.81 mg/dL; 95% CI, −7.58 to −0.04; *p* = 0.04; non-Asian: −0.92 mg/dL; 95% CI, −3.01 to 1.16 mg/dL; *p* = 0.39; [Figure 5](#nutrients-11-00048-f005){ref-type="fig"}).

Meta-regression analysis indicated that the intervention duration did not modify the effects of green tea on FBG concentrations (β = 0.01; SE, 0.08; 95% CI, −0.16 to 0.19; *p* = 0.87; [Supplemental Figure S1b](#app1-nutrients-11-00048){ref-type="app"}). Meta-regression analysis also indicated that the percentage of male sex, BMI, and baseline FBG did not modify the effects of green tea on FBG concentrations (percentage of male sex: β = 0.04; SE, 0.03; 95% CI, −0.04 to 0.12; *p* = 0.25, BMI: β = −0.20; SE, 0.32; 95%, CI −0.92 to 0.52; *p* = 0.55, baseline FBG: β = −0.01; SE, 0.11; 95% CI, −0.25 to 0.24; *p* = 0.96). In a post-hoc stratified analysis according to non-diabetic \[[@B28-nutrients-11-00048],[@B29-nutrients-11-00048],[@B34-nutrients-11-00048],[@B36-nutrients-11-00048],[@B39-nutrients-11-00048]\], prediabetic (including subjects with metabolic syndrome) \[[@B31-nutrients-11-00048],[@B32-nutrients-11-00048],[@B35-nutrients-11-00048],[@B37-nutrients-11-00048]\], and diabetic subjects \[[@B30-nutrients-11-00048],[@B33-nutrients-11-00048]\], the significant effect of green tea on FBG concentrations was only evident in a subgroup with non-diabetic subjects (non-diabetic: −2.74 mg/dL; 95% CI, −5.19 to −0.29 mg/dL; *p* = 0.03, prediabetic: 1.13 mg/dL; 95% CI, −2.62 to 4.87 mg/dL; *p* = 0.56, diabetic: −4.76 mg/dL; 95% CI, −12.45 to 2.92 mg/dL; *p* = 0.23; [Supplemental Figure S1c](#app1-nutrients-11-00048){ref-type="app"}). Further, a post-hoc meta-regression analysis suggested that prediabetes or diabetes did not modify the effects of green tea on FBG concentrations (meta-regression heterogeneity; prediabetes: *p* = 0.24, diabetes: *p* = 0.64).

The oolong tea group also had lower FBG concentrations than did the water group in the NMA (−39.91 mg/dL; 95% CI, −62.04 to −17.78 mg/dL; *p* \< 0.001; [Table 2](#nutrients-11-00048-t002){ref-type="table"}) but not in the direct pairwise meta-analysis. However, the quality of evidence was very low because of a serious risk of bias due to unclear allocation concealment in all oolong tea studies and a potential financial bias, serious heterogeneity (I^2^ of 87.2%), and very serious imprecision due to having a small sample size and wide confidence interval. Coffee, decaffeinated coffee, black tea, and decaffeinated green tea did not show significant effects on FBG concentrations in either the direct pairwise meta-analysis or the NMA.

Ranking the effects of the interventions on FBG concentrations, after NMA, showed that oolong tea had a mean rank of 1.0 (surface under the cumulative ranking curve (SUCRA), 1.0), black tea had a mean rank of 2.8 (SUCRA, 0.7), and green tea had a mean rank of 3.8 (SUCRA, 0.7). The oolong tea intervention had a one-order larger effect on FBG concentrations as compared with the other interventions, although the quality of evidence was very low. The resulting large heterogeneity in effect sizes across the interventions may have led to unstable NMA estimates. However, excluding the oolong tea studies did not materially change the NMA results ([Supplemental Table S2](#app1-nutrients-11-00048){ref-type="app"}). As shown in the comparison-adjusted funnel plot ([Supplemental Figure S2](#app1-nutrients-11-00048){ref-type="app"}), there was no apparent evidence of asymmetry.

3.4. Secondary Endpoints: {#sec3dot4-nutrients-11-00048}
-------------------------

### 3.4.1. 75-g OGTT 2h-PG {#sec3dot4dot1-nutrients-11-00048}

Four studies \[[@B22-nutrients-11-00048],[@B23-nutrients-11-00048],[@B28-nutrients-11-00048],[@B33-nutrients-11-00048]\] reported the effects of the interventions on 75-g OGTT 2h-PG concentrations, including two studies \[[@B28-nutrients-11-00048],[@B33-nutrients-11-00048]\] involving green tea and two \[[@B22-nutrients-11-00048],[@B23-nutrients-11-00048]\] involving both coffee and decaffeinated coffee. Neither the direct pairwise meta-analysis nor the NMA showed any significant effects associated with coffee, decaffeinated coffee, or green tea on 75-g OGTT 2h-PG concentrations relative to a placebo/water ([Table 3](#nutrients-11-00048-t003){ref-type="table"}, [Supplemental Figure S3](#app1-nutrients-11-00048){ref-type="app"}). The comparison-adjusted funnel plot ([Supplemental Figure S4](#app1-nutrients-11-00048){ref-type="app"}) does not show any evidence of asymmetry.

### 3.4.2. HbA1c {#sec3dot4dot2-nutrients-11-00048}

Ten studies reported the interventions' effects on HbA1c, including 1 \[[@B24-nutrients-11-00048]\] showing the effects of coffee, six \[[@B31-nutrients-11-00048],[@B32-nutrients-11-00048],[@B33-nutrients-11-00048],[@B36-nutrients-11-00048],[@B37-nutrients-11-00048],[@B38-nutrients-11-00048]\] showing the effects of green tea, 2 \[[@B41-nutrients-11-00048],[@B43-nutrients-11-00048]\] showing the effects of decaffeinated green tea, and 1 \[[@B47-nutrients-11-00048]\] showing the effects of oolong tea. Thus, we conducted meta-analyses examining green tea (6 studies \[[@B31-nutrients-11-00048],[@B32-nutrients-11-00048],[@B33-nutrients-11-00048],[@B36-nutrients-11-00048],[@B37-nutrients-11-00048],[@B38-nutrients-11-00048]\]) and decaffeinated green tea (2 studies \[[@B41-nutrients-11-00048],[@B43-nutrients-11-00048]\]) vs. placebo/water. Neither direct pairwise meta-analysis nor NMA showed any significant effect for these interventions on HbA1c ([Table 4](#nutrients-11-00048-t004){ref-type="table"}, [Supplemental Figure S5](#app1-nutrients-11-00048){ref-type="app"}). The comparison-adjusted funnel plot ([Supplemental Figure S6](#app1-nutrients-11-00048){ref-type="app"}) does not show any asymmetry related to green tea.

### 3.4.3. Fasting IRI {#sec3dot4dot3-nutrients-11-00048}

Fifteen studies \[[@B21-nutrients-11-00048],[@B22-nutrients-11-00048],[@B23-nutrients-11-00048],[@B24-nutrients-11-00048],[@B28-nutrients-11-00048],[@B30-nutrients-11-00048],[@B31-nutrients-11-00048],[@B33-nutrients-11-00048],[@B36-nutrients-11-00048],[@B40-nutrients-11-00048],[@B41-nutrients-11-00048],[@B42-nutrients-11-00048],[@B43-nutrients-11-00048]\] reported the effects of the interventions on fasting IRI concentrations relative to a placebo/water, including two \[[@B21-nutrients-11-00048],[@B24-nutrients-11-00048]\] involving coffee, two \[[@B22-nutrients-11-00048],[@B23-nutrients-11-00048]\] involving both coffee and decaffeinated coffee, five \[[@B28-nutrients-11-00048],[@B30-nutrients-11-00048],[@B31-nutrients-11-00048],[@B33-nutrients-11-00048],[@B36-nutrients-11-00048]\] involving green tea, and four \[[@B40-nutrients-11-00048],[@B41-nutrients-11-00048],[@B43-nutrients-11-00048]\] involving decaffeinated green tea. Only coffee showed significant impacts on fasting IRI concentrations, in both the direct pairwise meta-analyses (+1.1 μIU/mL; 95% CI, 0.22.0 μIU/mL; [Supplemental Figure S7](#app1-nutrients-11-00048){ref-type="app"}) and in the NMA (+1.1 μIU/mL; 95% CI, 0.2--2.0 μIU/mL; [Table 5](#nutrients-11-00048-t005){ref-type="table"}). However, the comparison-adjusted funnel plot ([Supplemental Figure S8](#app1-nutrients-11-00048){ref-type="app"}) did not show any evidence of asymmetry.

### 3.4.4. HOMA-IR {#sec3dot4dot4-nutrients-11-00048}

Eight studies \[[@B22-nutrients-11-00048],[@B23-nutrients-11-00048],[@B30-nutrients-11-00048],[@B31-nutrients-11-00048],[@B32-nutrients-11-00048],[@B41-nutrients-11-00048],[@B42-nutrients-11-00048],[@B43-nutrients-11-00048]\] reported the effects of the interventions on HOMA-IR, including two involving both coffee and decaffeinated coffee \[[@B22-nutrients-11-00048],[@B23-nutrients-11-00048]\], 3 \[[@B30-nutrients-11-00048],[@B31-nutrients-11-00048],[@B32-nutrients-11-00048]\] involving green tea, and three \[[@B41-nutrients-11-00048],[@B42-nutrients-11-00048],[@B43-nutrients-11-00048]\] involving decaffeinated green tea. There were no significant effects of these interventions on HOMA-IR levels relative to placebo/water in the direct pairwise meta-analysis or in the NMA ([Table 6](#nutrients-11-00048-t006){ref-type="table"}, [Supplemental Figure S9](#app1-nutrients-11-00048){ref-type="app"}). Additionally, the comparison-adjusted funnel plot ([Supplemental Figure S10](#app1-nutrients-11-00048){ref-type="app"}) did not show any evidence of asymmetry.

4. Discussion {#sec4-nutrients-11-00048}
=============

In this systematic review and NMA, we evaluated the effects of various coffee and tea consumptions on glucose metabolism across available RCT data. We found 27 studies, involving 1898 subjects with study durations of 4--72 weeks. With regard to the primary endpoint, the studies with a moderate quality of evidence suggested that green tea consumption, but not consumption of caffeinated/decaffeinated coffee or black tea, may reduce FBG concentrations, as compared with a placebo/water. The effect estimates were also statistically significant for oolong tea, but the quality of evidence was very low due to the risk of bias and imprecision in the studies. As for the secondary endpoint, studies with a moderate quality of evidence indicated that caffeinated coffee consumption may increase insulin concentrations. The potential effects of green tea on glucose metabolism have substantial public health implications given the global diabetes epidemic, such that even a small potential downward shift in the distribution of FBG concentrations would result in substantial numbers of individuals avoiding diabetes. Although further efforts are required to confirm the evidence, our findings support the notion that green tea may be a preventative strategy for reducing the number of people developing diabetes.

Some mechanisms have been suggested to explain the ability of green tea to reduce FBG concentrations. Previous rodent-based studies reported that the potential beneficial effect of green tea on glucose metabolism may be mediated by epigallocatechin gallate (EGCG), the most abundant catechin present in green tea \[[@B48-nutrients-11-00048]\]. Waltner-Law et al. reported that EGCG reduces hepatic glucose production by increasing tyrosine phosphorylation of the insulin receptor and insulin receptor substrate-1 in H4IIE rat hepatoma cell models \[[@B49-nutrients-11-00048]\]. Recent studies have also suggested that green tea increases insulin sensitivity and glucose metabolism, helping to prevent type 2 diabetes from developing. Ortsäter et al. also reported that EGCG preserves islet structure and enhances glucose tolerance in genetically diabetic mice (young *db*/*db* mice) \[[@B50-nutrients-11-00048]\]. Further, Ueda et al. reported that EGCG may reduce hyperglycemic events by promoting glucose transporter-4 translocation in skeletal muscle via a mechanism that is partially different from the action of insulin because EGCG promoted the translocation in insulin-resistant L6 myotubes and had neither a synergistic nor an additive effect on insulin \[[@B51-nutrients-11-00048]\]. Surprisingly, Fu et al. reported that EGCG increases the concentrations of the circulating anti-inflammatory cytokine, interleukin-10, and delayed type 1 diabetes onset in non-obese diabetic mice \[[@B52-nutrients-11-00048]\]. In our meta-analysis, green tea and its extract reduced FBG concentrations. In the NMA, the effect of green tea on FBG concentrations was confined to younger (\< 55-years-old) subjects. Beta-cell function is known to decrease continuously from euglycemia until the onset of type 2 diabetes \[[@B53-nutrients-11-00048],[@B54-nutrients-11-00048]\]. Therefore, early green tea intervention, which may help maintain beta-cell function, might be a prerequisite for its potential effects on FBG concentrations, at least via the proposed beta-cell protection mechanism. The reason for the discrepancy between results derived from Asian-based studies and non-Asian-based studies is unclear. In both Asian and non-Asian studies, 75% of studies used green tea extract for the intervention. If the EGCG content was not provided, we assumed that one cup of green tea contains 110 mg of EGCG \[[@B32-nutrients-11-00048]\] and 100 mg of green tea extract contains 21.4 mg of EGCG \[[@B29-nutrients-11-00048]\] from similar studies. The mean daily EGCG doses were not different between the Asian and non-Asian studies (367.3 ± 175.5 mg/day vs. 374.6 ± 186.8 mg/day, *p* = 0.95). The meta-regression analysis showed there was no significant interaction between daily the EGCG dose contained in green tea and the FBG (β = 0.00; SE, 0.01; 95% CI, −0.02 to 0.01; *p* = 0.54; [Supplemental Figure S11](#app1-nutrients-11-00048){ref-type="app"}).

One possible explanation could be the differences in dietary habits or genetic predisposition for impaired glucose metabolism that might interact with the glucose-lowering effects of green tea. However, further investigations are certainly needed to understand this possible ethnic difference. Caffeine is known to reduce insulin sensitivity in the short term and have adverse effects such as arrhythmias, pregnancy complications, and drug interactions from clinical trials \[[@B55-nutrients-11-00048]\]. Thus, such potential risks associated with caffeine should also be evaluated in order to make recommendations regarding caffeine-related beverages such as caffeinated coffee and tea. In our meta-analysis, green tea reduced FBG levels but did not reduce HbA1c levels. Two-thirds of the included green tea studies with HbA1c data were followed up in less than 12 weeks. This might be too short a period for assessing the effects for change in HbA1c levels accurately.

Oolong tea also showed potential protective effects on FBG concentrations in the NMA. Both green tea and oolong tea are derived from *Camellia sinensis*, with their only difference being in the level of fermentation; green tea is unfermented whereas oolong tea is partially fermented. Therefore, both may exert protective effects on glucose metabolism through similar mechanisms. However, the two oolong tea studies included in our meta-analysis were supported by oolong tea manufacturers and had a very low quality of evidence due to the presence of very serious risks of bias and serious imprecisions. Thus, our inferences regarding the potential protective effects of oolong tea are limited. Indeed, a five-day, cross-over trial of 19 participants failed to show the protective effects of oolong tea on glucose metabolism, i.e., FBG concentrations and incremental glucose areas under the concentration time curve remained largely unchanged in the trial arms \[[@B56-nutrients-11-00048],[@B57-nutrients-11-00048],[@B58-nutrients-11-00048]\]. To assess the true effects of oolong tea on glucose metabolism, more precisely designed, larger-scale RCTs are required. A series of prospective cohort studies reported that coffee and decaffeinated coffee intakes were linked to reducing the risk of type 2 diabetes \[[@B57-nutrients-11-00048]\]. In a meta-analysis and systematic review that summarized the findings from 28 prospective studies, the relative risk of diabetes associated with a 1-cup/day consumption increase was 0.91 (95% CI, 0.89--0.94) for caffeinated coffee consumption and 0.94 (95% CI, 0.91--0.98) for decaffeinated coffee consumption \[[@B21-nutrients-11-00048]\]. Further, these findings also suggested a dose-response relationship. However, in our meta-analysis, coffee and decaffeinated coffee consumption were unrelated to FBG concentrations. Furthermore, our meta-analysis showed that coffee resulted in slight increases in fasting IRI concentrations, raising concerns that coffee may impair insulin sensitivity. Because the follow-up periods of the included studies were far shorter than for the cohort studies and the total number of participants of coffee trials was small (below optimal information criterion), the long-term effect of coffee on glucose metabolism remains uncertain and longer (a few years) RCTs with a sufficient number of participants are required.

To date, this meta-analysis is the most comprehensive analysis, using a combined NMA and GRADE approach to evaluate the effects of tea and coffee on glucose metabolism. However, several limitations merit further consideration. First, complete blinding of coffee or tea interventions is difficult due to their taste. Thus, most studies were conducted using an open-label design. Second, the study durations were relatively short (median, 9 weeks; interquartile range, 6.5--16 weeks). Therefore, additional randomized studies, having longer durations and sufficient washout periods, are needed to determine the long-term effects of coffee and tea consumption on glucose metabolism.

5. Conclusions {#sec5-nutrients-11-00048}
==============

In conclusion, this systematic review and NMA of 27 studies, involving 1898 subjects and having a moderate quality of evidence, indicates that green tea consumption, compared with a placebo/water, might slightly lower FBG concentrations. Oolong tea consumption also resulted in significant decreases in FBG concentrations in the NMA but the studies suffered from a very low quality of evidence. Further, studies with a moderate quality of evidence indicated that caffeinated coffee consumption may increase insulin concentrations. The effects of consuming coffee or tea on HbA1c, 75-g OGTT 2h-PG, HOMA-IR, and HOMA-ß are limited and uncertain. Although further efforts are required to confirm the benefit of green tea on glucose metabolism, our study provides supportive evidence that green tea might lower FBG concentrations, possibly leading to a reduction in the number of people developing diabetes as a result of regular consumption.
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nutrients-11-00048-t001_Table 1

###### 

Characteristics of the included studies.

  Study ID                                           Study Design   Population                                        Country       Interventions                            Outcomes                Total Sample Size   Duration of Intervention (weeks)   Age      Male Sex (%)   BMI (kg/m^2^)   Baseline FBG (mg/dL)
  -------------------------------------------------- -------------- ------------------------------------------------- ------------- ---------------------------------------- ----------------------- ------------------- ---------------------------------- -------- -------------- --------------- ----------------------
  van Dam 2004 \[[@B21-nutrients-11-00048]\]         Crossover      Healthy volunteers                                Netherlands   Coffee/no coffee                         FBG, F-IRI              26                  4                                  37.0     38             23.0            NR
  Wedick 2011 \[[@B22-nutrients-11-00048]\]          Parallel       Overweight                                        US            Coffee/decaf coffee/no coffee            FBG, 2hPG, F-IRI, IR    45                  8                                  40.6     35             29.5            86.4
  Ohnaka 2012 \[[@B23-nutrients-11-00048]\]          Parallel       Overweight men with IFG                           Japan         Coffee/decaf coffee/water                FBG, 2hPG, F-IRI, IR    43                  16                                 52.7     100            25-30           107.6
  Shaposhnikov 2016 \[[@B24-nutrients-11-00048]\]    Parallel       Healthy volunteers                                Germany       Coffee/water                             FBG, A1c, F-IRI,        160                 8                                  51.0     NR             26.5            97.2
  Duffy 2001 \[[@B25-nutrients-11-00048]\]           Crossover      CAD                                               US            Black tea/water                          FBG                     50                  4                                  55.0     78             29.7            121.5
  Mukamal 2007 \[[@B26-nutrients-11-00048]\]         Parallel       Diabetes or 2 other cardiovascular risk factors   US            Black tea/water                          FBG                     28                  26                                 65.8     36             29.1            97.0
  Bahorun 2012 \[[@B27-nutrients-11-00048]\]         Parallel       Healthy subjects                                  Mauritius     Black tea/water                          FBG                     77                  12                                 25--74   55             NR              125.5
  Chan 2006 \[[@B28-nutrients-11-00048]\]            Parallel       Obese women with polycystic ovary syndrome        China         Green tea extract/placebo                FBG, 2hPG, F-IRI        34                  13                                 25--40   0              30.1            92.6
  Diepvens 2006 \[[@B29-nutrients-11-00048]\]        Parallel       Overweight female                                 Netherlands   Green tea extract/placebo                FBG                     46                  12                                 41.7     0              27.7            93.6
  Ryu 2006 \[[@B30-nutrients-11-00048]\]             Crossover      T2D                                               Korea         Green tea/water                          FBG, F-IRI, IR          55                  4                                  53.9     56             25.0            NR
  Fukino 2008 \[[@B31-nutrients-11-00048]\]          Crossover      Prediabetes                                       Japan         Green tea extract/water                  FBG, A1c, F-IRI, IR     60                  9                                  53.6     85             25.7            137.7
  Basu 2010 \[[@B32-nutrients-11-00048]\]            Parallel       Obesity & MetS                                    US            Green tea/green tea extract/water        FBG, A1c, IR            35                  8                                  42.5     49             36.2            88.2
  Mirzaei 2010 \[[@B33-nutrients-11-00048]\]         Parallel       T2D                                               Iran          Green tea extract/placebo                FBG, 2hPG, A1c, F-IRI   102                 8                                  54.6     21             29.2            172.1
  Suliburska 2012 \[[@B34-nutrients-11-00048]\]      Crossover      Obese                                             Poland        Green tea extract/placebo                FBG                     46                  13                                 50.4     50             32.8            101.8
  Vieira Senger 2012 \[[@B35-nutrients-11-00048]\]   Parallel       MetS                                              Brazil        Green tea/no green tea                   FBG                     45                  9                                  ≥60      16             30.5            119.0
  Wu 2012 \[[@B36-nutrients-11-00048]\]              Parallel       Postmenopausal women                              US            Green tea extract/placebo                FBG, A1c, F-IRI,        103                 9                                  59.8     0              29.3            99.7
  Toolsee 2013 \[[@B37-nutrients-11-00048]\]         Parallel       Prediabetes                                       Mauritius     Green tea/water                          FBG, A1c,               117                 14                                 48.3     51             25.6            91.6
  Lasaite 2014 \[[@B38-nutrients-11-00048]\]         Parallel       T2D                                               Lithuania     Green tea extract/placebo                A1c                     31                  78                                 57.0     38             NR              NR
  Shin 2017 \[[@B39-nutrients-11-00048]\]            Parallel       After endoscopic polypectomy                      Korea         Green tea extract/no Green tea extract   FBG                     143                 52                                 59.7     68             23.9            101.7
  Brown 2011 \[[@B40-nutrients-11-00048]\]           Crossover      Healthy overweight and obese men                  UK            Decaf green tea extract/placebo          FBG, F-IRI              66                  6                                  49.4     100            31.5            107.1
  Hsu 2011 \[[@B41-nutrients-11-00048]\]             Parallel       T2D                                               Taiwan        Decaf green tea extract/placebo          FBG, A1c, F-IRI, IR     68                  16                                 51.3     35             29.8            173.0
  Belcaro 2013 \[[@B42-nutrients-11-00048]\]         Parallel       MetS                                              Italia        Decaf green tea extract/placebo          FBG                     98                  24                                 46.5     50             31.0            115.9
  Liu 2014 \[[@B43-nutrients-11-00048]\]             Parallel       T2D with dyslipidemia                             Taiwan        Decaf green tea extract/placebo          FBG, A1c, F-IRI, IR     77                  16                                 54.3     42             26.3            145.6
  Dostal 2016 \[[@B44-nutrients-11-00048]\]          Parallel       Obese women                                       US            Decaf green tea extract/placebo          FBG, F-IRI, IR          237                 52                                 60.7     0              28.2            97.4
  Lu 2016 \[[@B45-nutrients-11-00048]\]              Parallel       Women with acne                                   Taiwan        Decaf green tea extract/placebo          FBG                     64                  4                                  29.1     0              21.2            87.6
  Hosoda 2003 \[[@B46-nutrients-11-00048]\]          Crossover      T2D                                               Taiwan        Oolong tea/water                         FBG                     20                  4                                  61.2     50             22.6            NR
  Shimada 2004 \[[@B47-nutrients-11-00048]\]         Crossover      CAD                                               Japan         Oolong tea/water                         FBG, A1c                22                  4                                  64.3     77             23.0            170.5

Abbreviations: 2hPG; 75-g 2-h oral glucose tolerance test results for blood glucose; A1c, HbA1c; BMI, body mass index; CAD, coronary artery disease; F-IRI, fasting blood insulin; FBG, fasting blood glucose; IFG, impaired fasting glucose; IR, HOMA-IR; MetS: metabolic syndrome; NR, not reported; T2D, type 2 diabetes.

nutrients-11-00048-t002_Table 2

###### 

Intervention effect on fasting blood glucose vs. placebo/water.

  Intervention                         Number of Studies in Pairwise Comparison   Number of Participants in Pairwise Comparison   Mean Difference (95% CI, mg/dL)   I^2^ (%)   Quality of Evidence
  ------------------------------------ ------------------------------------------ ----------------------------------------------- --------------------------------- ---------- ---------------------
  Coffee (pairwise)                    4                                          247                                             1.34 (−0.52 to 3.20)              0.0        Low ^a^
  Coffee (NMA)                                                                                                                    1.27 (−1.18 to 3.71)                         
  Decaffeinated coffee (pairwise)      2                                          55                                              5.28 (−5.34 to 15.91)             0.0        Low ^b^
  Decaffeinated coffee (NMA)                                                                                                      4.12 (−5.41 to 13.65)                        
  Black tea (pairwise)                 3                                          155                                             −3.56 (−8.80 to 1.68)             0.0        Low ^c^
  Black tea (NMA)                                                                                                                 −3.51 (−9.09 to 2.07)                        
  Green tea (pairwise)                 11                                         786                                             −2.10 (−3.93 to −0.27)            12.5       Moderate ^d^
  Green tea (NMA)                                                                                                                 −2.09 (−3.96 to −0.24)                       
  Decaffeinated green tea (pairwise)   6                                          610                                             −0.23 (−2.84 to 2.38)             0.0        Low ^e^
  Decaffeinated green tea (NMA)                                                                                                   −0.44 (−3.53 to 2.64)                        
  Oolong tea (pairwise)                2                                          42                                              −38.72 (−100.56 to 23.11)         87.2       Very low ^f^
  Oolong tea (NMA)                                                                                                                −39.91 (−62.04 to −17.78)                    

^a^ Downgraded two levels because of a serious risk of bias due to unclear allocation concealment in studies with large weight and serious imprecision due to having a small sample size (below optimal information criterion). ^b^ Downgraded two levels because of very serious imprecision due to having a small sample size (below optimal information criterion) and wide confidence interval. ^c^ Downgraded two levels because of serious risk of bias in blinding of participants in all studies and serious imprecision due to having a small sample size (below optimal information criterion). ^d^ Downgraded one level because of serious risk of bias due to unclear allocation concealment in studies with large weight. ^e^ Downgraded two levels because of serious risk of bias due to unclear allocation concealment in studies with large weight and serious imprecision due to having a small sample size (below optimal information criterion). ^f^ Downgraded three levels because of serious risk of bias due to unclear allocation concealment in all studies and potential financial bias; serious heterogeneity (I^2^ of 87.2%) and very serious imprecision due to having a small sample size (below optimal information criterion) and wide confidence intervals.
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###### 

Intervention effect on 2-h oral glucose tolerance test results for blood glucose vs. placebo/water.

  Intervention                      Number of Studies   Number of Intervention   Mean Difference (95% CI) (mg/dL)   I^2^ (%)   Quality of Evidence
  --------------------------------- ------------------- ------------------------ ---------------------------------- ---------- ---------------------
  Coffee (pairwise)                 2                   61                       −23.99 (−63.78 to 15.81)           66.4       Very low ^a^
  Coffee (NMA)                                                                   −17.89 (−44.95 to 9.18)                       
  Decaffeinated coffee (pairwise)   2                   55                       12.27 (−8.52 to 33.07)             0.0        Low ^b^
  Decaffeinated coffee (NMA)                                                     12.20 (−11.33 to 35.73)                       
  Green tea (pairwise)              2                   138                      −8.25 (−27.11 to 10.61)            0.0        Moderate ^c^
  Green tea (NMA)                                                                −8.35 (−29.40 to 12.70)                       

^a^ Downgraded three levels because of serious risk of bias due to inadequate allocation concealment in all studies (designed as coffee vs no coffee), high heterogeneity (I^2^ = 66.4), serious imprecision due to having a small sample size, and wide confidence interval. ^b^ Downgraded two levels because of serious risk of bias due to distinguishable allocation in all studies (designed as decaffeinated coffee vs no coffee), serious imprecision due to having a small sample size, and wide confidence interval. ^c^ Downgraded one level because of a small sample size (below optimal information criterion) and wide confidence interval.
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###### 

Intervention effect on HbA1c vs. placebo/water.

  Intervention                         Number of Studies   Number of Interventions   Mean Difference (95% CI) (mg/dL)   I^2^ (%)   Quality of Evidence
  ------------------------------------ ------------------- ------------------------- ---------------------------------- ---------- ---------------------
  Green tea (pairwise)                 6                   504                       0.00 (−0.15 to 0.16)               23.8       Low ^a^
  Green tea (NMA)                                                                    0.02 (−0.09 to 0.12)                          
  Decaffeinated green tea (pairwise)   2                   145                       −0.08 (−0.67 to 0.51)              0.0        Moderate ^b^
  Decaffeinated green tea (NMA)                                                      −0.08 (−0.67 to 0.51)                         

^a^ Downgraded two levels because of serious risk of bias due to unclear allocation concealment and serious imprecision due to having a small sample size (below optimal information criterion). ^b^ Downgraded one level because of serious imprecision due to having a small sample size (below optimal information criterion).
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###### 

Intervention effect on fasting blood insulin vs. placebo/water.

  Intervention                         Number of Studies   Number of Interventions   Mean Difference (95% CI) (mg/dL)   I^2^ (%)   Quality of Evidence
  ------------------------------------ ------------------- ------------------------- ---------------------------------- ---------- ---------------------
  Coffee (pairwise)                    4                   273                       1.10 (0.17 to 2.03)                0.0        Low ^a^
  Coffee (NMA)                                                                       1.10 (0.17 to 2.04)                           
  Decaffeinated coffee (pairwise)      2                   55                        0.00 (−4.99 to 5.00)               46.9       Very low ^b^
  Decaffeinated coffee (NMA)                                                         1.24 (−1.70 to 4.18)                          
  Green tea (pairwise)                 5                   469                       −0.11 (−0.67 to 0.45)              0.0        Low ^c^
  Green tea (NMA)                                                                    −0.11 (−0.67 to 0.45)                         
  Decaffeinated green tea (pairwise)   4                   510                       −0.51 (−2.16 to 1.13)              45.7       Moderate ^d^
  Decaffeinated green tea (NMA)                                                      −0.02 (−0.83 to 0.80)                         

^a^ Downgraded two levels because of serious risk of bias due to blinding of participants and personnel and serious imprecision due to having a small sample size (below optimal information criterion). ^b^ Downgraded three levels because of serious risk of bias due to blinding of participants and personnel, moderate heterogeneity (I^2^ = 46.9), serious imprecision due to having a small sample size (below optimal information criterion), and wide confidence interval. ^c^ Downgraded two levels because of serious risk of bias due to unclear allocation concealment in 4 out of 5 studies and serious imprecision due to having a small sample size (below optimal information criterion). ^d^ Downgraded one level because of moderate heterogeneity (I^2^ = 45.7) and small sample size (below optimal information criterion).
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###### 

Intervention effect on HOMA-IR vs. placebo/water.

  Intervention                         Number of Studies   Number of Interventions   Mean Difference (95% CI)   I^2^ (%)   Quality of Evidence
  ------------------------------------ ------------------- ------------------------- -------------------------- ---------- ---------------------
  Coffee (pairwise)                    2                   61                        0.04 (−0.75 to 0.83)       0.0        Low ^a^
  Coffee (NMA)                                                                       0.05 (−0.79 to 0.89)                  
  Decaffeinated coffee (pairwise)      2                   55                        0.14 (−1.13 to 1.41)       35.0       Very low ^b^
  Decaffeinated coffee (NMA)                                                         0.18 (−0.83 to 1.20)                  
  Green tea (pairwise)                 3                   265                       −0.11 (−0.62 to 0.39)      0.0        Low ^c^
  Green tea (NMA)                                                                    −0.10 (−0.68 to 0.48)                 
  Decaffeinated green tea (pairwise)   3                   382                       −0.08 (−1.12 to 0.95)      63.3       Very low ^d^
  Decaffeinated green tea (NMA)                                                      0.01 (−0.63 to 0.66)                  

^a^ Downgraded two levels because of serious risk of bias due to blinding of participants and serious imprecision due to small sample size (below optimal information criterion). ^b^ Downgraded three levels because of serious risk of bias due to blinding of participants, inconsistency of results, and serious imprecision due to small sample size (below optimal information criterion). ^c^ Downgraded two levels because of serious risk of bias due to blinding of participants and serious imprecision due to small sample size (below optimal information criterion). ^d^ Downgraded three levels because of serious risk of bias due to unclear allocation concealment, inconsistency of results, serious imprecision due to small sample size (below optimal information criterion), and wide confidence interval. HOMA-IR, homeostasis model assessment for insulin resistance.
